Earnings call Stereotaxis posted 36% YoY revenue growth in Q4 2025 and 20% full-year growth, fueled by new system and catheter launches despite manufacturing headwinds. Management guides for >$40M ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results